Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Revelation Biosciences, Inc. - Common Stock
(NQ:
REVB
)
0.8200
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 26, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Revelation Biosciences, Inc. - Common Stock
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
January 14, 2022
Happy Friday, trader! We're starting off the day right with an overview of the biggest pre-market stock movers for today!
Via
InvestorPlace
18 Stocks Moving in Friday's Pre-Market Session
January 14, 2022
Gainers Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) shares rose 17.6% to $0.8350 in pre-market trading after dropping around 9% on Thursday. NextPlay Technologies, Inc...
Via
Benzinga
48 Biggest Movers From Yesterday
January 14, 2022
Gainers Singularity Future Technology Ltd. (NASDAQ: SGLY) shares rose 25.9% to settle at $5.01 on Thursday. MedAvail Holdings, Inc (NASDAQ: MDVL) gained 24.4% to settle at $1.58...
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
January 18, 2022
Tuesday morning saw 454 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Unilever (NYSE:UL) was the largest firm by market cap to set a...
Via
Benzinga
52 Biggest Movers From Friday
January 18, 2022
Gainers Splash Beverage Group, Inc. (NASDAQ: SBEV) shares gained 118.9% to settle at $4.18 on Friday. Splash Beverage recently announced it has received authorization to sell its...
Via
Benzinga
30 Stocks Moving In Friday's Mid-Day Session
January 14, 2022
Gainers ATI Physical Therapy, Inc. (NYSE: ATIP) shares gained 25.2% to $3.8050 after Jefferies upgraded the stock from Hold to Buy and raised its price target from $3.50 to $5....
Via
Benzinga
EXCLUSIVE: New On NASDAQ Deck, Revelation Bio's COVID-19 Antiviral Shows Encouraging Preclinical Action
January 11, 2022
Revelation Biosciences Inc (NASDAQ: REVB) says that it observed a significant decrease in viral load with the prophylactic treatment of REVTx-99 in models of COVID-19 infection....
Via
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.